Businesses that have qualified R&D expenditures in Maryland may qualify for the R&D Tax Credit. The tax credit is equal to ten percent (10%) of eligible R&D expenses incurred during the taxable year in excess of the Maryland Base Amount. If the total credits applied for exceed the statutory caps, the business’s R&D tax credit is prorated. The total statutory cap is $12 million with a small business set-aside of $3.5 million.  A single applicant may not receive a tax credit exceeding $250,000.

Companies involved in a variety of stem cell with significant commercialization can apply for grants of up to $400,000 to help them advance their technologies.

Companies with proprietary technology and a competitive advantage in the market may apply for $500k to $1.5M investment from the Maryland Venture Fund.

Investors in Montgomery County biotechnology companies who are approved to receive tax credits for 33% of their eligible investment up to $250,000 from the Maryland Biotechnology Investment Incentive Tax Credit Program automatically receive an additional supplemental grant (amounts vary annually) from the County.

Supplemental grant available to investors in biotechnology companies located in the county. Approved investors that receive Maryland State tax credits will automatically receive the supplemental grant.

For life sciences companies constructing new facilities are exempt from the County’s development tax; this exemption can be worth millions in savings, depending on square footage.